These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Enhancement of recovery from psychiatric illness by methylfolate. Godfrey PS; Toone BK; Carney MW; Flynn TG; Bottiglieri T; Laundy M; Chanarin I; Reynolds EH Lancet; 1990 Aug; 336(8712):392-5. PubMed ID: 1974941 [TBL] [Abstract][Full Text] [Related]
6. Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Treatment Strategies in Schizophrenia Collaborative Study Group. Glick ID; Jacobs M; Lieberman J; Simpson G; Schooler NR Psychopharmacol Bull; 1989; 25(3):344-7. PubMed ID: 2626513 [No Abstract] [Full Text] [Related]
7. Folic acid and folates. Preface. Litwack G Vitam Horm; 2008; 79():xvii-xviii. PubMed ID: 18804689 [No Abstract] [Full Text] [Related]
8. Do neuroleptics cause depression? Roy A Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454 [TBL] [Abstract][Full Text] [Related]
9. A non-linear mathematical model for computerized analysis of mood curves: construction of the model and its application to the mood curves of depressive and schizophrenic inpatients. Möller HJ; Leitner M J Affect Disord; 1988; 14(3):203-11. PubMed ID: 2898491 [TBL] [Abstract][Full Text] [Related]
10. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia. Barnes TR; Liddle PF; Curson DA; Patel M Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915 [No Abstract] [Full Text] [Related]
11. The dysphoric syndrome in schizophrenia and its implications for relapse. Hirsch SR; Jolley AG Br J Psychiatry Suppl; 1989 Jul; (5):46-50. PubMed ID: 2690890 [No Abstract] [Full Text] [Related]
12. Antidepressant usage in schizophrenia. Plasky P Schizophr Bull; 1991; 17(4):649-57. PubMed ID: 1687176 [TBL] [Abstract][Full Text] [Related]
13. L-methylfolate (Deplin) for depression. Med Lett Drugs Ther; 2010 Apr; 52(1336):31-2. PubMed ID: 20407417 [No Abstract] [Full Text] [Related]
14. [Value of neuroleptic therapy in the self assessment of schizophrenic patients]. Heim M Psychiatr Neurol Med Psychol (Leipz); 1987 Aug; 39(8):487-91. PubMed ID: 3685210 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients]. Langlois-Thery S; Dollfus S; Lesieur P; Petit M Encephale; 1994; 20(5):487-93. PubMed ID: 7828511 [TBL] [Abstract][Full Text] [Related]
16. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication. Lewine RR Am J Psychiatry; 1990 Nov; 147(11):1463-6. PubMed ID: 1977328 [TBL] [Abstract][Full Text] [Related]
17. Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients. Pickar D; Davis GC; Schulz SC; Extein I; Wagner R; Naber D; Gold PW; van Kammen DP; Goodwin FK; Wyatt RJ; Li CH; Bunney WE Am J Psychiatry; 1981 Feb; 138(2):160-6. PubMed ID: 6257125 [TBL] [Abstract][Full Text] [Related]
18. Experience of negative symptoms: comparison of schizophrenic patients to patients with a depressive disorder and to normal subjects. Selten JP; Gernaat HB; Nolen WA; Wiersma D; van den Bosch RJ Am J Psychiatry; 1998 Mar; 155(3):350-4. PubMed ID: 9501744 [TBL] [Abstract][Full Text] [Related]